Study period | |||||||
---|---|---|---|---|---|---|---|
 | Pre-admission | Preoperative phase | Postoperative phase | Discharge | |||
Timepointa | −t1 | t0 | t1 | t2 | t3 | t4 | t5 |
Enrolment: | |||||||
 Eligibility | X |  |  |  |  |  |  |
 Informed consent | X |  |  |  |  |  |  |
 Screen Anxiety level |  | X |  |  |  |  |  |
 Allocation |  | X |  |  |  |  |  |
Interventions: | |||||||
 VR exposure |  |  |  | X |  |  |  |
Assessments: | Â | Â | Â | Â | Â | Â | Â |
 Primary outcome: |  |  | X | X | X |  |  |
  Perioperative anxiety |  |  |  |  |  |  |  |
 Secondary outcomes: |  |  | X | X | X |  |  |
  Stress level |  |  |  |  |  |  |  |
  Pain |  |  | X |  | X |  |  |
  Patient satisfaction |  |  |  |  |  | X |  |
  Length of hospital stay |  |  |  |  |  |  | X |
  VR adverse effect |  |  |  | X |  |  |  |